Claire Burton c.burton@keele.ac.uk
P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial
Burton, Claire L; Rathod-Mistry, Trishna; Blagojevic-Bucknall, Milica; Chesterton, Linda S; Davenport, Graham; Dziedzic, Krysia S; Jowett, Sue M; Myers, Helen L; Oppong, Raymond A; der Windt, Danielle A. Van; Hay, Elaine M; Roddy, Edward
Authors
Trishna Rathod-Mistry
Milica Bucknall m.bucknall@keele.ac.uk
Linda S Chesterton
Graham Davenport
Professor Krysia Dziedzic k.s.dziedzic@keele.ac.uk
Sue M Jowett
Helen L Myers
Raymond A Oppong
Danielle Van Der Windt d.van.der.windt@keele.ac.uk
Elaine Hay e.m.hay@keele.ac.uk
Edward Roddy e.roddy@keele.ac.uk
Abstract
Background
Patients with mild-to-moderate carpal tunnel syndrome (CTS) are commonly treated with night splints and/or local corticosteroid injection. In the INSTINCTS (INjection versus SplinTing in Carpal Tunnel Syndrome) trial, we previously reported that a single corticosteroid injection is more effective than night splinting at 6 weeks but not at 6 months. The aims of follow-up at 12 and 24 months were to examine whether corticosteroid injection is clinically and cost-effective in reducing symptoms in the longer-term compared to night splinting and to compare rates of CTS surgery.
Methods
INSTINCTS was a pragmatic clinical trial in adults ≥18 years with mild-to-moderate CTS diagnosed using standardised clinical criteria. Participants were recruited from primary care or musculoskeletal interface services and randomised 1:1 to receive either a single carpal tunnel injection of 20mg methylprednisolone acetate or a night splint. Follow-up questionnaires were mailed at 6 weeks and 6, 12 and 24 months. Key clinical outcomes at 12 and 24 months were the Boston Carpal Tunnel Questionnaire (BCTQ), hand/wrist pain intensity (0-10 numeric rating scale (NRS)) and the number of patients referred for and receiving CTS surgery. Longitudinal mixed effect models were fitted to estimate overall treatment effect at each time point by including interaction terms between treatment and time, adjusted for age, gender, symptom duration and baseline score. The cumulative number (%) of participants i) referred or ii) undergoing CTS surgery were examined by treatment group. Cost-utility analysis was conducted from an NHS perspective to determine the cost-effectiveness of injection versus night splinting.
Results
118 participants were randomised to night splinting and 116 to corticosteroid injection. In the splint group, 88 (78%) and 81 (74%) completed follow-up at 12 and 24 months respectively compared to 87 (77%) and 78 (72%) in the injection group. There were no statistically significant differences between splint and injection groups in BCTQ score at 12 (adjusted mean difference -0.09; 95%CI -0.30, 0.12) or 24 months (0.06; -0.16, 0.28) or hand pain NRS (12 months 0.03; -0.79, 0.85. 24 months 0.41; -0.45, 1.26). By 24-month follow-up, a greater proportion of the injection group had been referred for (28% vs 20%) and undergone (22% vs 16%) CTS surgery than the splint group. Injection was more costly (mean difference £68.59 (-120.84, 291.24)) with lower quality-adjusted life-years (QALYs) than splinting over 24 months (mean difference -0.022 (-0.074, 0.024)).
Conclusion
To our knowledge, this is the longest-reported follow-up of a randomised trial investigating the conservative management of CTS, with the largest sample size. Over 24-months, there were no differences in symptoms between groups and injection was not cost-effective compared with splinting. Surgical referral and intervention rates were low overall, but slightly more frequent in the injection group.
Citation
Burton, C. L., Rathod-Mistry, T., Blagojevic-Bucknall, M., Chesterton, L. S., Davenport, G., Dziedzic, K. S., …Roddy, E. (2020). P143 The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome: 24-month follow-up of an open-label, parallel group, randomised controlled trial. Rheumatology, 59(Supplement_2), https://doi.org/10.1093/rheumatology/keaa111.138
Journal Article Type | Conference Paper |
---|---|
Conference Name | British Society for Rheumatology Annual Conference 2020 |
Online Publication Date | Apr 20, 2020 |
Publication Date | Apr 1, 2020 |
Deposit Date | Jun 28, 2023 |
Journal | Rheumatology |
Print ISSN | 1462-0324 |
Electronic ISSN | 1462-0332 |
Publisher | Oxford University Press |
Peer Reviewed | Peer Reviewed |
Volume | 59 |
Issue | Supplement_2 |
DOI | https://doi.org/10.1093/rheumatology/keaa111.138 |
Keywords | Pharmacology (medical); Rheumatology; patient referral; adrenal corticosteroids; carpal tunnel syndrome; cost effectiveness; costs and benefits; glucocorticoids; adult; disclosure; follow-up; injections; instinct; primary health care; quality-adjusted li |
You might also like
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search